chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable consumer or other non-HCP (patient himself). A 26-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6206) via intramuscular route of administration in left deltoid (Left shoulder) on 13Mar2021 at 10:27 (age at the time of vaccination was 26-year-old) as dose 2, single for COVID-19 immunization. The patient's medical history included asthma and allergy from 10May2001 and still ongoing, ongoing dust allergy, ongoing allergy to animal allergy to cat, dogs, ongoing mycotic allergy (molds like alternaria alternata) and weakened immune system due to doing inhaled with corticosteroids from 10May2001 and still ongoing. The concomitant medication included fluticasone propionate, salmeterol xinafoate (ADVAIR) via nasal route of administration (inhalation), taken as a strength of 500/50 mcg for asthma maintenance from Dec2020 and still ongoing, salbutamol (ALBUTEROL HFA (Pro Air)) via nasal route of administration (inhalation) taken for asthma (rescue inhaler) from 2001 and still ongoing, montelukast sodium (MONTELUKAST SODIUM) via oral route of administration taken as a dose of 10mg for Allergy/Asthma from 2019 and still ongoing, azelastine (AZELASTINE) via nasal route of administration (inhalation) taken as a dose of 137 ug (mcg) for allergy from Feb2021 and still ongoing. Historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9266) via intramuscular route of administration in right deltoid (Right shoulder) on 21Feb2021 at 13:55 (age at the time of vaccination was 26-year-old) as dose 1, single for COVID-19 immunization and experienced 2 days Fatigue and aches on 21Feb2021 at 14:30. The vaccination facility type reported as other. The vaccine was not administered at military facility. The Prior vaccinations (within 4 weeks) reported as none. The patient experienced fatigue, aches, nausea, vomiting on 13Mar2021 at 12:00. The patient underwent lab tests and procedures which included sars-cov-2 test (Covid-19 Active infection) with results not detected, Likely other sickness on 29Aug2020. The duration of all events reported as 3 days. No treatment received for the events. The clinical outcome of all events was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.
Case reference number 1999024471 is a spontaneous report from a 50 year old female patient. A few months prior to Havrix therapy, the pt developed shingles on her chin which resolved. ON 09/03/1999, the pt received her 1st TX with Havrix at an unspecified dose for prophylaxis. Approximately 2 days later, 09/05/99, she experienced a very sore throat, sinus problems, chest problems and a cough. The symptoms are ongoing.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Metastic stage 3C Melanoma survivor" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
no adverse effects, patient received total of 4 covid vaccines. Received full moderna series, then completed a series of pfizer
I had chills I was so cold. I had a fever, body aches, sore throat, headache, arm pain wear I got the shot. I was hot my clothes was so wet from sweating.
This was reported after the fact by the patients doctor. The patient began to have rippling lines in her breast, one week after receiving the vaccine. She began seeking treatment at her PCP and was sent to Doctor at the center. According to Dr. she presented with creases and dents in her left breast. A mammogram was negative. A left breast ultrasound was then preformed, and found branches of superficial thrombosed veins in her left breast. Dr. believes it is related to the covid vaccine. Patient was then sent to the ER for fear of DVT. Patient was found to have no DVTs and was diagnosed with superficial thrombophlebitis and sent home.
Around 6pm or so I started feeling  nauseous,  itching at site of injection,  red, swollen with fever. Tightness of chest, wheezing,  throat irritation,  dizziness,  headache,  weakness,  anxiety,  change in eyesight  where it comes and goes,  muscles and joint pain.  Just  really hurting all over. Upset stomach,  feeling tired and unwell.  My eyes also have mucus in them and vision comes and goes. I have felt okay during the day until around 6pm the symptoms occur and last the rest of the night. My arm also is painful at injection site and swollen , kind of like a knot.  This is the next day after injection. When I had the first shot I had same reactions and it lasted 4 days.
Arm hurts really bad; Aches in the body; High fever; feeling like getting sick; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced such as running a high fever all the night and morning, fever over 102f, arm hurts really bad, aches in the body, feeling like getting sick.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 19/01/2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 19/01/2021, The patient experienced the events such as running a high fever all the night and morning, fever over 102f, arm hurts really bad, aches in the body, feeling like getting sick.  Laboratory details are not provided.   No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events are not provided.
No additional AE reported; Improperly stored vaccine was administered to patient; This spontaneous report was received from a medical assistant and refers to a 15-month-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 08-DEC-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, administered intramuscularly in right thigh for prophylaxis,lot #W018828, expiration date: 14-JUN-2024 (lot #W018828 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) [VARIVAX]). Administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) had undergone temperature excursion on 05-DEC-2022 (product storage error). There were no adverse events reported (no adverse event).  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-2304USA007822:Original Case : 2303USA002114 US-009507513-2304USA007836: US-009507513-2304USA007843: US-009507513-2304USA007931:
Post vax, child had increased temperature of 100.5F and complaint of tenderness on right deltoid. Area on arm is warm with some swelling noted.
Caller experienced pain in thigh; weakness a day after; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for covid-19 immunisation. The following information was reported: MYALGIA (non-serious) with onset 03Mar2021, outcome "unknown", described as "Caller experienced pain in thigh"; ASTHENIA (non-serious) with onset 03Mar2021, outcome "unknown", described as "weakness a day after". Additional information: . Caller wanted to know whether it was a normal reaction after the dose. No any unaddressed medical questions referred or forwarded to Medical Information.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a pharmacist via a company representative referring to a male patient of unknown age. On an unknown date the patient was vaccinated with a single shot of ZOSTAVAX (lot# and route were not reported). Approximately in 2014 (reported as 1 year ago) the patient developed a rash up his arm after receiving ZOSTAVAX. The patient did not seek medical attention. The outcome of the event was unknown. The relationship between the event and ZOSTAVAX was not reported. Additional information has been requested.
HPI Generic: 8-year-old girl here with mother and brother for evaluation of rash. She is here accompanying her brother while he is here for his physical. She was seen last week for well-child check. She received a varicella vaccine. 2 days later she developed itching and rash to the injection site. Then she also developed scattered pruritic lesions throughout the trunk. She had moderate sore throat with subjective low-grade fever and chills. No cough, wheeze, chest pain or difficulty breathing. No abdominal pain or vomiting. Sore throat and fever have resolved. The rash is starting to improve.
About 16 hours post-injection, I have a large bump at the injection site with increasing redness over the course of the first 24 hours. The area is extremely sensitive and very warm. I also woke up with a huge migraine, bad nauseous, extreme tiredness, and muscle aches. I was not running a fever but felt extremely warm.
My arm is now very red and  warm.; It is starting to feel like my arm is weak and achy; My arm is now very red and  warm.; It is starting to feel like my arm is weak and achy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (My arm is now very red and  warm.), PAIN IN EXTREMITY (It is starting to feel like my arm is weak and achy), SKIN WARM (My arm is now very red and  warm.) and MUSCULAR WEAKNESS (It is starting to feel like my arm is weak and achy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced ERYTHEMA (My arm is now very red and  warm.), PAIN IN EXTREMITY (It is starting to feel like my arm is weak and achy), SKIN WARM (My arm is now very red and  warm.) and MUSCULAR WEAKNESS (It is starting to feel like my arm is weak and achy). At the time of the report, ERYTHEMA (My arm is now very red and  warm.), PAIN IN EXTREMITY (It is starting to feel like my arm is weak and achy), SKIN WARM (My arm is now very red and  warm.) and MUSCULAR WEAKNESS (It is starting to feel like my arm is weak and achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment medication reported.
arrived @ MD office weak-diff breathing-was given 02 transported to hosp by ambulance dx w/polio through exclusion;
This case was reported by a other health professional via call center representative and described the occurrence of pain in a adult male patient who received SHINGRIX for prophylaxis. In December 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain. SHINGRIX was discontinued. On an unknown date, the outcome of the pain was recovered/resolved. It was unknown if the reporter considered the pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but the patient was in his 20's at the time of reporting. The patient had enough pain that he was in bed for nearly 24 hours, and was very painful for 24 hours more. The patient was never in bed for so long over his twenty years and would not receive the 2nd dose of SHINGRIX, nor the several other vaccine recipients had spoken with asking to make something better.
Grand mal seizure; Condition aggravated; This spontaneous case was reported by a consumer and describes the occurrence of GENERALISED TONIC-CLONIC SEIZURE (Grand mal seizure) and SYMPTOM RECURRENCE (Condition aggravated) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Grand mal seizure. Concomitant products included LEVETIRACETAM (KEPPRA XR) for Grand mal seizure.    In November 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced GENERALISED TONIC-CLONIC SEIZURE (Grand mal seizure) (seriousness criteria hospitalization and medically significant) and SYMPTOM RECURRENCE (Condition aggravated) (seriousness criteria hospitalization and medically significant). At the time of the report, GENERALISED TONIC-CLONIC SEIZURE (Grand mal seizure) and SYMPTOM RECURRENCE (Condition aggravated) outcome was unknown.            No Treatment medication was provided. Patient was on anti-seizure medication Keppra still he got his first seizure. While on COVID-19 Patient had daily seizure and he took 9 months of cognitive therapy for the same. Doctor advised him not to take COVID vaccine due to his current condition.  Company comment: This is a spontaneous case concerning a male patient of unknown age with relevant medical history of grand mal seizure, who experienced the unexpected, serious, AESI event of grand mal seizure and unexpected, serious event of symptom recurrence. The events grand mal seizure and symptom recurrence occurred 1 day after the second dose of mRNA-1273 vaccine administration. The rechallenge was not applicable. The medical history of grand mal seizure remain confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a male patient of unknown age with relevant medical history of grand mal seizure, who experienced the unexpected, serious, AESI event of grand mal seizure and unexpected, serious event of symptom recurrence. The events grand mal seizure and symptom recurrence occurred 1 day after the second dose of mRNA-1273 vaccine administration. The rechallenge was not applicable. The medical history of grand mal seizure remain confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
tingling, pins and needles sensation from their hip to their toes on injection side; This is a spontaneous report from a contactable pharmacist. A 37-years-old female patient received first dose of bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, Solution injection; Batch/Lot number was not reported), via an unspecified route of administration on 05Aug2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 07Aug2021, patient experienced tingling, pins and needles sensation from their hip to their toes on injection side. Pharmacist did not provide specific date or time. No injection site issues noted. Pharmacist verifies that patient has an appointment tomorrow morning with Primary Care Physician and is currently seeing a Chiropractor. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
In addition to common headache, tiredness, lightheadedness and nausea, am having vision problems in right eye.  Vision is blurry or even blank.
Initial case received from a consumer who is the patient on 23 September 2014. A 56 year old male patient, was vaccinated with a Flu Vaccine (manufacturer, batch, route and site of administration not reported) last year in "2013?" on an unspecified date. The patient has a history of previous Epstein-Barr infection. A couple of days after vaccination, he felt achy with generalized pain as if he had the flu. He was extremely tired. He reported that a couple of months later he was diagnosed with recurrence for Epstein-Barr virus. He is continuing to experience extreme tiredness and continues with Epstein-Barr infection. Laboratory tests and concomitant medications were not reported. Treatments were not reported. He received the flu vaccine at his own healthcare provider. The patient outcome is not recovered. Documents held by sender: None. Follow-up pregnancy report received from a non-healthcare professional on 01 Dec 2014. Date of vaccination was reported as 11-Oct-2013. Batch number of INFLUENZA VACCINE was reported as UN900AE and the site of vaccination was right deltoid. Date of event onset for recurrence of Epstein-Barr infection, altered cognitive function/ altered mental status, disturbance of skin sensation/ arm paresthesia, headache, extreme tiredness/malaise and fatigue, generalized pain as if he had the flu and he also felt achy on 13-Oct-2013. Any other vaccination within 4 weeks prior to date listed and adverse event following prior vaccination was reported as none. Illness at the time of vaccination was reported as CFIOS. Asthma and Anxiety was reported since 2006. Documents held by sender: none.
My arm was sore for 3 days following the Covid vaccine injection on 1/20/21.  Then it seemed completely normal until today (1/29/21). I woke up this morning and it felt warm and hard. It is also slightly itchy. I have an area that is red over the injection site, it is a 3" x 3".  It feels worse tonight. A little more achy and sore. Also feels hotter, more swollen and firmer.
Within a month of receiving the second dose I had two menstrual cycles, which has never happened in my life. Exactly one month after the second dose my symptoms began and included: reactive arthritis that was so debilitating I could not walk or stand. Vertigo that was so debilitating I could not work or drive. Confusion, memory problems, and trouble thinking also prevented me from working for 3 months. I also experienced extreme fatigue, which has continued for these past 7 months. The reactive arthritis, neuropathy, and muscle pain has slowly improved, but I am still receiving physical therapy and vestibular therapy for the vertigo. I was in the ER, and have visited at least 5 different doctors including a neurologist. The neurologist ordered an MRI of my brain. None of these doctors have found any evidence of COVID infection (both of my COVID tests were negative on July 4 2021 when I visited an urgent care center) and none of them have provided any answers for my health problems. Dr. has determined it was an adverse reaction to the COVID-19 vaccine.
Three hours after receiving the first dose of Moderna COVID vaccine, he experienced the worst headache of his life. He described it as intense pressure and constant pain. This headache continued for 6 days. It has since went away, but at the time it made it difficult for him to function.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 08Oct2021 at 12:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 42 years, in right arm for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results; negative, notes: Rebound case after testing negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Began with feeling sick, like from a cold/flu around 5 pm. Around 7 pm felt achy joints. From 7-8 chills and still sick. From 8 pm on into the night, fever. Hot spells very very achy in back, neck, and legs. Unable to sleep.
Tightness in center and left side of chest within 3/4 days of vaccine, lasting 3-4 weeks after each dose. Some shortness of breath and fatigue along with 3rd dose.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, in Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm and in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "thyroid disease" (unspecified if ongoing); "obese" (unspecified if ongoing); "past cancer" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; NEXIUM [ESOMEPRAZOLE SODIUM]; GABAPENTIN; BABY ASPIRIN; MAGNESIUM; CALCIUM; TURMERIC [CURCUMA LONGA RHIZOME]. Past drug history included: Amoxicillin, reaction(s): "known allergies; amoxicillin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19".  Clinical course: Patient got COVID 19 and took Plaxlovid. Patient tested negative 6 days later and then three days after that patient had symptoms and tested positive again. Paxlovid treatment start date = 11Jul2022, Treatment stop date = 16Jul2022. Other medication in 2 weeks product include multi vitamin.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recvd vax; pt devel fever; abdominal pain; nausea which inc after each of 1st 2 inject;
Hand and wrist joint pain starting at Day 5 through Day 8 3" x 4" red welt with itching surrounding injection site starting at Day 8 and continuing (today is Day 10)
Tingling of the tongue, racing pulse (104 to 112 resting), abscess  in left armpit for a week, difficulty walking for two days (was off Tuesday 10/12/21 ) - I work nights and had to call off work on  the night of Wednesday 10/13/21 because I found it difficult to walk or stand.
Dizziness-persists Nausea- persists Tachycardia-resolved weakness
Pt did not develop a titer p/vax series; a booster dose was given;
Heavier, prolonged periods lasting upto 10 days starting 2 days after 1 dose of Covid vaccine. Has continued for 3 full menstrual cycles so far.